Fungal Infections (DBCOND0032278)

Identifiers

Synonyms
Infection, Fungal / Fungal Infection / Infection fungal / Any fungal infection / Infections, Fungal / Fungal infections / Mycoses / Mycosis (disorder) / Mycosis / Fungal infection NOS / Fungemia NOS / Infection mycotic / Fungal infectious disorders / Infection fungal (mycotic)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Amphotericin B
An antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis.
Benzoic acid
An antimicrobial food additive.
Bifonazole
An azole antifungal drug used to treat fungal skin infections, such as dermatomycosis.
Caspofungin
An echinocandin used to treat a variety of fungal infections.
Chloroxine
An antibacterial agent used for the treatment of dandruff and mild to moderately severe seborrheic dermatitis of the scalp.
Fenticonazole
An imidazole antifungal used to treat a variety of topical fungal infections.
No drug targets
Fluconazole
A triazole antifungal used to treat various fungal infections including candidiasis.
Flucytosine
An antifungal indicated only to treat severe infections throughout the body caused by susceptible strains of Candida or Cryptococcus.
Gentian violet cation
An antiseptic violet dye used to prevent various infections, including fungal and bacterial infections.
Ketoconazole
A broad spectrum antifungal used to treat seborrheic dermatitis and fungal skin infections.
Micafungin
An antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation.
Posaconazole
A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients.
Salicylic acid
An acid used to treat acne, psoriasis, calluses, corns, keratosis pilaris, and warts.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Voriconazole
A triazole compound used to treat fungal infections.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00342589
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00034645
Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Diseaseprevention3completed
NCT02888197
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida ColonizationNo drug interventionsNot AvailableNot Availablecompleted
NCT00841971
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipientsprevention4completed
NCT00177788
Voriconazole as Prophylaxis for Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00726609
Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)Not AvailableNot Availablecompleted
NCT00034632
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)treatment3completed
NCT02676570
Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular MethodNo drug interventionsNot AvailableNot Availableunknown_status
NCT02683642
Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT02244606
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasistreatment2completed
NCT01254318
Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)No drug interventionsNot AvailableNot Availablecompleted
NCT00413218
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infectionstreatment3completed
NCT00034658
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)treatment3completed
NCT00002122
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patientstreatment3completed
NCT00002325
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are CommontreatmentNot Availablecompleted
NCT00673348
Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean PopulationsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000826
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolitestreatment1completed
NCT00015665
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infectionstreatment3completed
NCT00336531
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantationprevention4completed
NCT02734862
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extensiontreatment2completed
NCT01829204
Prospective Data Bank Creation to Study Vaginal ConditionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01122368
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjectsprevention2completed
NCT00784368
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infectiontreatment3completed
NCT00005912
Voriconazole to Prevent Systemic Fungal Infections in Childrentreatment1completed
NCT00890708
Therapeutic Drug Monitoring of VoriconazoletreatmentNot Availablecompleted
NCT00002038
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal TherapytreatmentNot Availablecompleted
NCT03667690
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasistreatment3completed
NCT00001790
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropeniatreatment1completed
NCT04265521
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry FeetNo drug interventionstreatmentNot Availablecompleted
NCT00686621
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)Not AvailableNot Availableapproved_for_marketing
NCT02492802
Effect of Inflammation on Pharmacokinetics of PosaconazoleNot AvailableNot Availablecompleted
NCT00704951
Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)Not AvailableNot Availablewithdrawn
NCT00002277
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infectionstreatment3completed
NCT00896493
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphomatreatment2completed
NCT00034671
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)treatment2completed
NCT00001937
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patientstreatment3completed
NCT00550732
A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)treatment2completed
NCT02733432
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infectionstreatment2completed
NCT04368559
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantationprevention3recruiting
NCT01315925
Pre-hospital Risk Factors for Invasive Fungal InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01307930
Effect of Weight and/or Obesity on Anidulafungin Drug Concentrationsother4completed
NCT00001757
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infectionstreatment3completed
NCT04157465
Anti-fungal Strategies in Acute-on-Chronic Liver Failure PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT01260974
Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipientsprevention2unknown_status
NCT01058174
Liver Transplant European Study Into the Prevention of Fungal Infectionprevention3completed
NCT00000676
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)prevention3completed
NCT00001280
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Diseasetreatment2completed
NCT00001940
Voriconazole to Treat Fungal Infectionstreatment3completed
NCT01232504
Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCTprevention4completed
NCT01772212
Bioequivalence Study for Terbinafine 250 mgother1completed
NCT03923010
A Study of Itraconazole in the Management of Superficial Fungal Infections in Indiaprevention4terminated
NCT00001810
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infectionstreatment3completed
NCT03429023
Descriptive Epidemiology on Management of MucormycosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00300677
To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Daysbasic_science4completed
NCT01222741
Studies of Disorders With Increased Susceptibility to Fungal InfectionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00177684
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)prevention3completed
NCT02631954
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteerstreatment1completed
NCT05336851
Emergency PWAS in Respiratory Infectious DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT01105013
Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infectionstreatment3unknown_status
NCT01716234
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)treatment1terminated
NCT00876096
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal InfectionsNo drug interventionsdiagnosticNot Availablecompleted
NCT01782131
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)treatment3completed
NCT03793231
fungalAi for Fungal Surveillance & Antifungal StewardshipNo drug interventionsNot AvailableNot Availableunknown_status
NCT00794703
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infectionsprevention3completed
NCT01436578
Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)Not AvailableNot Availablecompleted
NCT06483815
Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective ComparisonNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02025699
Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or SepsisNo drug interventionsNot AvailableNot Availablecompleted
NCT02358499
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Childrenother1completed
NCT00353158
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicitybasic_science1completed
NCT01777763
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)prevention1completed
NCT02306330
MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic TrialNo drug interventionsdiagnosticNot Availablecompleted
NCT01684189
Registry of Febrile Neutropenia and Invasive Fungal InfectionsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00606268
A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplantprevention1completed
NCT00177710
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Studyprevention3completed
NCT06220370
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04961593
PK/PD of Caspofungin in Children Severe InfectionNot AvailableNot Availablerecruiting
NCT03674359
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.No drug interventionsNot AvailableNot Availableunknown_status
NCT05686577
How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive CareNo drug interventionsNot AvailableNot Availablecompleted
NCT03005353
Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.treatment2 / 3completed
NCT04287504
Point-of-care Tests for Bacterial Vaginosis and CandidosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01904188
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?No drug interventionsNot AvailableNot Availablerecruiting
NCT03230058
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitistreatment2 / 3unknown_status
NCT05814432
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDStreatment3not_yet_recruiting
NCT05235711
The Role of Interferon-gamma in Immune Responses to Invasive CandidiasisNo drug interventionsNot AvailableNot Availablecompleted
NCT05150327
Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01169402
Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)treatment1completed
NCT03336502
Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)prevention1completed
NCT01075984
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)prevention1completed
NCT04035187
Itraconazole Oral Absorptionbasic_science4completed
NCT03941951
Study to Optimize the Use of New AntibioticsNo drug interventionstreatmentNot Availableunknown_status
NCT00333645
Prophylaxis With Caspofungin in High-Risk Liver Transplantationprevention2unknown_status
NCT00386997
ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemiaprevention4terminated
NCT06417983
Topical Application of Essential Oils to Treat OnchomycosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01288378
Empirical Versus Preemptive Antifungal Therapysupportive_care3completed
NCT01667107
A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)prevention4terminated
NCT01371656
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantationsupportive_care3completed
NCT02674685
Vfend Special Investigation For ProphylaxisNo drug interventionsNot AvailableNot Availablecompleted
NCT03561415
Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung TransplantNo drug interventionsprevention2unknown_status
NCT03399032
Pharmacokinetics of CaspofunginNot AvailableNot Availablecompleted
NCT04804059
A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Malestreatment1completed
NCT00811642
Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)treatment3completed
NCT03857399
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungintreatment2completed
NCT06510699
Pharmacogenomics for Better Treatment of Fungal Infections in CancerNo drug interventionstreatment2not_yet_recruiting
NCT00177749
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095prevention4terminated
NCT00936117
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemiatreatment2completed
NCT00514358
Fluconazole Pharmacokinetics in InfantsNo drug interventionsNot AvailableNot Availablecompleted
NCT04476758
Immune Profiles in CF Fungal InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT04215458
Microbiota in Skin and Mucosa of Patients With Inflammatory Skin DiseasesNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT02445235
Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT01101386
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous DialysisNot AvailableNot Availablecompleted
NCT02544230
Granulocyte Transfusions in Hematological Patients With Febrile NeutropeniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00635648
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)treatment3completed
NCT05368948
The Assessment of Antimicrobial Peptides Against Fungal InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01318148
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxisprevention2completed
NCT00817765
Pharmacokinetic Study of Posaconazole Boosted Fosamprenavirtreatment1completed
NCT06025682
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INONo drug interventionsNot AvailableNot Availablerecruiting
NCT03828773
PTX3-targeted Antifungal ProphylaxispreventionNot Availablerecruiting
NCT03760276
A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimenother1completed
NCT03659162
Efflux Pump Mediated Azole Resistance in Candida AlbicansNo drug interventionsNot AvailableNot Availableunknown_status
NCT05876962
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University HospitalNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02957929
Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orallytreatment1completed
NCT00842504
Alternate Day Micafungin: A PK Study in Pediatric Patientsbasic_science1completed
NCT00430469
Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipientsprevention1 / 2withdrawn
NCT00904995
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxistreatment3completed
NCT01490138
Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)No drug interventionsNot AvailableNot Availableunknown_status
NCT00686543
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)prevention4completed
NCT00379964
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)treatment3completed
NCT01307579
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemiasupportive_care3completed
NCT00906633
Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian CentersNo drug interventionsNot AvailableNot Availablecompleted
NCT04818853
COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)No drug interventionsNot AvailableNot Availablecompleted
NCT00371605
An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot StudyNo drug interventionsNot AvailableNot Availableterminated
NCT02227797
MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patientstreatment1completed
NCT02387983
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)prevention1completed
NCT00292071
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)treatment2completed
NCT04273178
Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationNo drug interventionsprevention2unknown_status
NCT02154178
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)No drug interventionstreatmentNot Availablecompleted
NCT05283278
Effect of Administration of Combined Enteral Lactoferrin and Probiotic On Invasive Fungal Infections In Preterm Neonatesprevention1completed
NCT01419678
Pharmacokinetic Analysis of Posaconazole in Lung Transplant RecipientsNo drug interventionsdiagnosticNot Availablecompleted
NCT04117607
Safety and Pharmacokinetics of Rezafunginprevention1terminated
NCT01503515
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplantsupportive_care3completed
NCT03318159
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patientsprevention2completed
NCT05152875
Relationship Between Fungal Colonization and Severe Bronchopulmonary DysplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04684342
Fungal Infection in Patients in Intensive Care UnitsNo drug interventionsscreeningNot Availableunknown_status
NCT02956499
Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjectstreatment1completed
NCT01303549
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipientstreatment4completed
NCT03260634
The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.Not AvailableNot Availableunknown_status
NCT03292224
Systemic Fungal Infections in ICU PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05642624
The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic ShockNot AvailableNot Availablecompleted
NCT06582186
Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithmtreatment4not_yet_recruiting
NCT03650439
Fungal Infections in Patients With Hematological MalignanciesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04647539
Emerging Invasive Fungal Infections in Critically Ill PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01416025
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosingtreatment4completed
NCT05202366
An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01062165
Effect of Weight and/or Obesity on Caspofungin Drug ConcentrationsNot Available4completed
NCT04188574
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the ToenailNo drug interventionstreatment2completed
NCT04307082
ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjectsother1completed
NCT03641131
Ampholipad Real-World Data in TaiwanNo drug interventionsNot AvailableNot Availablecompleted
NCT00717860
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)treatment3completed
NCT02074462
Effect of Inflammation on Voriconazole ConcentrationNo drug interventionsNot AvailableNot Availablecompleted
NCT00548080
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)treatment3completed
NCT00740389
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.treatment1completed
NCT00177944
Invasive Fungal Infections Surveillance InitiativeNo drug interventionsNot AvailableNot Availablecompleted
NCT03434704
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazoletreatment2completed
NCT00136968
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance SpectroscopyNot Available1completed
NCT03731169
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood LevelsNo drug interventionstreatment4completed
NCT04166669
A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001treatment1completed
NCT03717623
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplantstreatment4recruiting
NCT03814343
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosistreatment4completed